NANO MRNA Co.,Ltd.
Biotechnology firm creating and out-licensing IP for mRNA-based therapeutics.
4571 | T
Overview
Corporate Details
- ISIN(s):
- JP3651120002
- LEI:
- Country:
- Japan
- Address:
- 港区愛宕二丁目５番１号
- Website:
- https://www.nanomrna.co.jp/
Description
NANO MRNA Co., Ltd. is a biotechnology firm that operates as a platform company and an IP Generator specializing in mRNA-based medicine. The company focuses on creating and out-licensing intellectual property for novel therapeutics by connecting drug discovery seeds with medical and development needs. It leverages a proprietary drug delivery system (DDS) based on micellar nanoparticle technology to advance its pipeline. Key clinical programs include an mRNA therapy for osteoarthritis (RUNX1 mRNA) and an antisense oligonucleotide (ASO) for glioblastoma (TUG1 ASO). Evolving from its predecessor, NanoCarrier, the company combines a legacy of R&D in nanoparticle technology with a strategic focus on RNA drug discovery. It also co-developed and markets Comlex®, an antibacterial agent for ear, nose, and throat conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-11-11 07:02 |
四半期報告書－第27期第2四半期(令和4年7月1日－令和4年9月30日)
|
Japanese | 163.2 KB | ||
| 2022-08-10 08:02 |
確認書
|
Japanese | 8.1 KB | ||
| 2022-08-10 08:02 |
四半期報告書－第27期第1四半期(令和4年4月1日－令和4年6月30日)
|
Japanese | 140.2 KB | ||
| 2022-06-28 08:04 |
内部統制報告書－第26期(令和3年4月1日－令和4年3月31日)
|
Japanese | 21.3 KB | ||
| 2022-06-28 08:03 |
確認書
|
Japanese | 8.1 KB | ||
| 2022-06-28 08:02 |
有価証券報告書－第26期(令和3年4月1日－令和4年3月31日)
|
Japanese | 746.6 KB | ||
| 2022-03-11 07:05 |
訂正四半期報告書－第26期第3四半期(令和3年10月1日－令和3年12月31日)
|
Japanese | 114.5 KB | ||
| 2022-02-10 07:02 |
四半期報告書－第26期第3四半期(令和3年10月1日－令和3年12月31日)
|
Japanese | 143.1 KB | ||
| 2021-11-12 07:04 |
四半期報告書－第26期第2四半期(令和3年7月1日－令和3年9月30日)
|
Japanese | 176.6 KB | ||
| 2021-08-13 08:32 |
四半期報告書－第26期第1四半期(令和3年4月1日－令和3年6月30日)
|
Japanese | 145.9 KB | ||
| 2021-06-25 08:22 |
確認書
|
Japanese | 8.1 KB | ||
| 2021-06-25 08:21 |
内部統制報告書－第25期(令和2年4月1日－令和3年3月31日)
|
Japanese | 21.3 KB | ||
| 2021-06-25 08:21 |
有価証券報告書－第25期(令和2年4月1日－令和3年3月31日)
|
Japanese | 771.2 KB | ||
| 2021-02-10 07:01 |
四半期報告書－第25期第3四半期(令和2年10月1日－令和2年12月31日)
|
Japanese | 140.2 KB | ||
| 2020-11-12 07:10 |
四半期報告書－第25期第2四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | 185.1 KB |
Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NANO MRNA Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
